Table 4.

Outcome at discharge and during the one-year follow up.

Characteristics Median [IQR] or n (%)	MD	All N = 488	AO	No AO	p value
ICU LOS (days)	0	5 (3–8)	6 [3–12]	5 [3–7]	0.0001
Hospital LOS (days)	14	12 [9–16]	14 [11–13]	11 [8–16]
Re-admissions in the ICU during the following year	58	129 (29.9)	18 (27.3)	111 (30.5)
Time to re-admission (days)	5	131 [31–244]	175 [86–279]	126 [14–239]
ICU mortality	0	16 (3.3)	16 (19.8)	0 (0)
Hospital mortality	0	18 (3.7)	17 (21)	1 (0.2)
One-year mortality	58	27 (6.3)	20 (29)	7 (2)

Significant values are in [bold].

The p values were obtained by univariate logistic regression and reflect associations with the occurrence of adverse outcomes. As “adverse outcome” was a composite criterion including death, no statistical tests were performed for re-admissions, ICU mortality, hospital mortality, or one-year mortality.

IQR interquartile range, MD missing data, AO adverse outcome defined as death or use of life-sustaining treatments, SCD sickle cell disease, MBP mean arterial blood pressure, GCS Glasgow Coma Scale, ASAT aspartate transaminase, ALAT alanine transaminase, LDH lactate dehydrogenase, PT prothrombin time, ICU intensive care unit, NSAIDs nonsteroidal anti-inflammatory drugs, RBC red blood cells, LOS length of stay, ACS acute chest syndrome, VOE vaso-occlusive event, NIV non-invasive ventilation, MV endotracheal mechanical ventilation, RRT renal replacement therapy, ECMO extracorporeal membrane oxygenation, SAPS II Simplified Acute Physiology Score II.